On November 21, the China Securities Regulatory Commission (CSRC) released its filing status update for domestic companies seeking overseas securities issuance and listings (including initial public offerings and full circulation) as of November 21, 2025.
This week (November 17–21), Demai Pharmaceutical's filing status was updated to "supplemental materials required." Meanwhile, Hot Energy Saving, Shima Pharmaceutical, Merit Medical, Canbot Robotics, and Defeng Technology have submitted IPO applications for Hong Kong listings, which have been accepted by the CSRC.
Additionally, full circulation applications for shares of UBOX ONLINE (02429), YT Pharma (02617), BAMA TEA (06980), INT MEDICAL (01501), and LIANLIAN (02598) have also been received by the CSRC.
Comments